Results 31 to 40 of about 213,106 (383)
Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction
Circulation: Heart Failure, 2020 Supplemental Digital Content is available in the text. Background: Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict outcomes in ...
R. Rørth +13 more
semanticscholar +1 more source
Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
BMC Cardiovascular Disorders, 2021 Background Novel circulating biomarkers may help in understanding the underlying mechanisms of atrial fibrillation (AF), a challenge for AF management and prevention of cardiovascular (CV) events.
L. Staszewsky +10 more
semanticscholar +1 more source
Respiratory Research, 2018 Background While the N-terminal pro-brain-type natriuretic peptide (NT-proBNP) at rest is known to be associated with prognosis in pulmonary arterial hypertension (PAH), it is unclear if the NT-proBNP response to exercise (ΔNT-proBNP) can contribute to a
J. Kutsch +4 more
doaj +1 more source
Levels of NT‑proBNP in patients with cancer
Oncology Letters, 2023 At present, it is well known that natriuretic peptides may be produced by cancer cells. Stimulation of N-terminal pro B-type natriuretic peptide (NT-proBNP) synthesis may be a reaction to activity of several proinflammatory cytokines. NT-proBNP is also a marker of myocardial damage during cardiotoxic chemotherapy by anthracyclines.
Jozef, Chovanec +3 more
openaire +2 more sources
Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes [PDF]
, 2012 <p>Background: Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression.
, +7 more
core +11 more sources
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021 Background Obese patients have lower NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) levels. The prognostic implications of achieving NT‐proBNP levels ≤1000 pg/mL in obese patients with heart failure (HF) receiving biomarker‐guided therapy are not ...
V. Parcha +6 more
semanticscholar +1 more source
The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension [PDF]
, 2015 We assessed the predictive ability of selected biomarkers using N-terminal pro-brain natriuretic peptide (NT-proBNP) as the benchmark and tried to establish a multi-biomarker approach to heart failure (HF) in hypertensive patients. In 120 hypertensive
Agata Bielecka-Dabrowa +10 more
core +2 more sources
ESC Heart Failure, 2022 Aims The N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) is a commonly used biomarker in heart failure for diagnosis and prognostication. We aimed to determine the prevalence of NT‐proBNP testing, distribution of NT‐proBNP concentrations, and ...
James L. Januzzi +6 more
doaj +1 more source
Cardiovascular Diabetology, 2021 Background The prognostic value of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with coronary artery disease (CAD) with different glucose status has not been established.
Huihui Liu +10 more
semanticscholar +1 more source
Majalah Kardiologi Indonesia, 2013 Background: Some research reports the usefulness of the N-terminal proBrain natriuretic peptide (NT proBNP) as a diagnostic tool for left ven-tricular hypertrophy due to increased levels of NT proBNP in hypertensive patients with left ventricular ...
Mohammad Ariful Munir, Djanggan Sargowo
doaj +1 more source